William McCulloch
No más puestos en curso
Origen de la red de primer grado William McCulloch.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a William McCulloch a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Founder | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| University of Michigan | College/University | Undergraduate Degree | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Federal University of Rio de Janeiro | College/University | Corporate Officer/Principal | |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Pharmaceuticals: Major | Director/Board Member | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Pharmaceuticals: Major | Director/Board Member | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member | |
| JIYA ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer | |
| Hemmo Pharma LLP | Director/Board Member | ||
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
| RAIN ONCOLOGY INC. | Biotechnology | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| St. Cloud State University | College/University | Undergraduate Degree | |
| The Curtis L. Carlson School of Management | College/University | Masters Business Admin | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OCUPHIRE PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Chief Executive Officer |
Estadísticas
Internacional
| Estados Unidos | 41 |
| Reino Unido | 3 |
| India | 3 |
| Suiza | 2 |
| Brasil | 2 |
Sectorial
| Health Technology | 33 |
| Consumer Services | 11 |
| Finance | 4 |
| Electronic Technology | 2 |
| Commercial Services | 2 |
Operativa
| Corporate Officer/Principal | 31 |
| Director/Board Member | 19 |
| Independent Dir/Board Member | 9 |
| Chief Executive Officer | 8 |
| Director of Finance/CFO | 6 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jinzi Wu | 20 |
| Rekha Hemrajani | 17 |
| Richard Rodgers | 13 |
| Eduardo Bruno Martins | 10 |
| Allan S. Wagman | 7 |
| Douglas I. Buckley | 5 |
| Dennis Hom | 4 |
- Bolsa de valores
- Insiders
- William McCulloch
- Conexiones Empresas
